Cercar

Barra de cerca
01/06/2025 Current Challenges in Dermatology Residency Training
Ferrer, AL. Current Challenges in Dermatology Residency Training. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2025.03.021. PMID:. IF:(Q/D).
01/05/2025 Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features
Angel-Baldo, J, Podlipnik, S, Azón, A, Boada, A, Arrieta, A, Marcoval, J, López-Sánchez, C, Sàbat , M, Segura, S, Bodet, D, Sabat, M, Curcó, N, Lopez-Castillo, D, Solà, J, Quintana-Codina, M, Baliu-Piqué, C, Martin-Sala, S, Just-Sarobé, M, Martín-Sala, S, Malvehy, J, Puig, S, Carrera, C, Marti, RM. Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features. Actas Dermo-Sifiliograficas. 2025; 116(5)DOI:10.1016/j.ad.2024.10.060. PMID:39798598. IF:(Q/D).
01/04/2025 RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE)
Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A. RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025 Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment
Escanilla, C, Schroder, C, Garrido, V, Balague, M, Ruiz, V, Toscas, JI, Cevallos, C. Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment. REVISTA MEDICA DE CHILE. 2025; 153(4)DOI:10.4067/s0034-98872025000400310. PMID:40493479. IF:0.300(Q4/8D).
01/04/2025 Clin. eff. & PROs in mod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant')
Augustin, M, Serra-Baldrich, E, Seneschal, J, Elrayes, M, Otero-Asman, JR, Berkery, E, Fakouri, W, Bewley, A, Garcia-Latasa, J, Pinter, A, Schlöbe, A. Clin. eff. & PROs in mod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant'). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025 RWeffectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment ( TRACE)
Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A. RWeffectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment ( TRACE). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025 Clin. eff. & PROs inmod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant')
Augustin, M, Serra-Baldrich, E, Seneschal, J, Elrayes, M, Otero-Asman, JR, Berkery, E, Fakouri, W, Bewley, A, García-Latasa, J, Pinter, A, Schlöbe, A. Clin. eff. & PROs inmod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant'). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/01/2025 MEAN ABSOLUTE EASI AND PRURITUS ACHIEVED BY LEBRIKIZUMAB OVER 16 WEEKS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Vestergaard, C, Thaci, D, Puig, L, Papp, KA, Gold, LS, Peñas, PF, Huan, YH, Dossenbach, M, Falques, M, Agell, H, Du Jardin, KG. MEAN ABSOLUTE EASI AND PRURITUS ACHIEVED BY LEBRIKIZUMAB OVER 16 WEEKS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).